BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38441654)

  • 21. Comparison of Outcomes Between Surveillance Ultrasound and Completion Lymph Node Dissection in Children and Adolescents With Sentinel Lymph Node-Positive Cutaneous Melanoma.
    Scoville SD; Stanek JR; Rinehardt H; Sutthatarn P; Abdelhafeez AH; Talbot LJ; Malek M; Leraas HJ; Tracy ET; Chen SY; Kim ES; Lotakis DM; Ehrlich PF; Favela JG; Le HD; Davidson J; Wilson CA; Seemann NM; Osman Y; Piche N; Hoang V; Petroze RT; Polites SF; McKay KG; Correa H; Lovvorn HN; Lee YM; Balagani A; Dasgupta R; Aldrink JH
    Ann Surg; 2024 Mar; 279(3):536-541. PubMed ID: 37487006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma.
    Guggenheim MM; Hug U; Jung FJ; Rousson V; Aust MC; Calcagni M; Künzi W; Giovanoli P
    Ann Surg; 2008 Apr; 247(4):687-93. PubMed ID: 18362633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Completion Lymph Node Dissection Based on Risk of Nonsentinel Metastasis in Cutaneous Melanoma of the Head and Neck.
    Fritsch VA; Cunningham JE; Lentsch EJ
    Otolaryngol Head Neck Surg; 2016 Jan; 154(1):94-103. PubMed ID: 26399717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymph node status and survival in cutaneous malignant melanoma--sentinel lymph node biopsy impact.
    Rutkowski P; Nowecki ZI; Nasierowska-Guttmejer A; Ruka W
    Eur J Surg Oncol; 2003 Sep; 29(7):611-8. PubMed ID: 12943629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of a scoring system to predict non-sentinel lymph node metastasis in melanoma.
    Cadili A; McKinnon G; Wright F; Hanna W; Macintosh E; Abhari Z; Dabbs K
    J Surg Oncol; 2010 Mar; 101(3):191-4. PubMed ID: 20039281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Final Analysis of DeCOG-SLT Trial: No Survival Benefit for Complete Lymph Node Dissection in Patients With Melanoma With Positive Sentinel Node.
    Leiter U; Stadler R; Mauch C; Hohenberger W; Brockmeyer NH; Berking C; Sunderkötter C; Kaatz M; Schatton K; Lehmann P; Vogt T; Ulrich J; Herbst R; Gehring W; Simon JC; Keim U; Verver D; Martus P; Garbe C;
    J Clin Oncol; 2019 Nov; 37(32):3000-3008. PubMed ID: 31557067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
    Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
    Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
    Nowecki ZI; Rutkowski P; Michej W
    Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Timing of completion lymphadenectomy after positive sentinel node biopsy in patients with melanoma.
    Oude Ophuis CM; van Akkooi AC; Rutkowski P; Powell WE; Robert C; Testori A; van Leeuwen BL; Siegel P; Eggermont AM; Verhoef C; Grünhagen DJ
    Br J Surg; 2017 May; 104(6):726-733. PubMed ID: 28218385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complete lymph node dissection or observation in melanoma patients with multiple positive sentinel lymph nodes: A single-center retrospective analysis.
    Persa OD; Knuever J; Mauch C; Schlaak M
    J Dermatol; 2018 Oct; 45(10):1191-1194. PubMed ID: 30095864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sentinel lymph node biopsy in acral melanoma: A Korean single-center experience with 107 patients (2006-2018).
    Sohng C; Sim HB; Kim JY; Lim Y; Han MH; Lee H; Ahn BC; Huh S; Lee SJ
    Asia Pac J Clin Oncol; 2021 Feb; 17(1):115-122. PubMed ID: 33079454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors associated with sentinel lymph node status and prognostic role of completion lymph node dissection for thick melanoma.
    Boada A; Tejera-Vaquerizo A; Ribero S; Puig S; Moreno-Ramírez D; Quaglino P; Osella-Abate S; Cassoni P; Malvehy J; Carrera C; Pigem R; Barreiro-Capurro A; Requena C; Traves V; Manrique-Silva E; Fernández-Orland A; Ferrandiz L; García-Senosiain O; Fernández-Figueras MT; Ferrándiz C; Nagore E;
    Eur J Surg Oncol; 2020 Feb; 46(2):263-271. PubMed ID: 31594672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Prognostic Significance of Sentinel Lymph Node Status for Patients with Thick Melanoma.
    Bello DM; Han G; Jackson L; Bulloch K; Ariyan S; Narayan D; Rothberg BG; Han D
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):938-945. PubMed ID: 27527717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stage IIIa Melanoma and Impact of Multiple Positive Lymph Nodes on Survival.
    Woeste MR; McMasters KM; Egger ME
    J Am Coll Surg; 2021 Apr; 232(4):517-524.e1. PubMed ID: 33316426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of sentinel lymph node tumour burden on additional lymph node involvement and disease-free survival in cutaneous melanoma--a retrospective analysis of 392 cases.
    Guggenheim M; Dummer R; Jung FJ; Mihic-Probst D; Steinert H; Rousson V; French LE; Giovanoli P
    Br J Cancer; 2008 Jun; 98(12):1922-8. PubMed ID: 18506141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of nonsentinel lymph node metastasis in malignant melanoma.
    Cadili A; Smylie M; Danyluk J; Dabbs K
    J Surg Res; 2009 Jun; 154(2):324-9. PubMed ID: 19101696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-related disparities in use of completion lymphadenectomy for melanoma sentinel lymph node metastasis.
    Shah DR; Yang AD; Maverakis E; Martinez SR
    J Surg Res; 2013 Nov; 185(1):240-4. PubMed ID: 23809182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sentinel Lymph Node Biopsy and Completion Lymph Node Dissection for Melanoma.
    Masoud SJ; Perone JA; Farrow NE; Mosca PJ; Tyler DS; Beasley GM
    Curr Treat Options Oncol; 2018 Sep; 19(11):55. PubMed ID: 30232648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sentinel lymph node micrometastasis may predict non-sentinel involvement in cutaneous melanoma patients.
    Glumac N; Hocevar M; Zadnik V; Snoj M
    J Surg Oncol; 2008 Jul; 98(1):46-8. PubMed ID: 18452214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sentinel lymph node biopsy in pediatric and adolescent cutaneous melanoma patients.
    Howman-Giles R; Shaw HM; Scolyer RA; Murali R; Wilmott J; McCarthy SW; Uren RF; Thompson JF
    Ann Surg Oncol; 2010 Jan; 17(1):138-43. PubMed ID: 19672660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.